ACACIA RESEARCH CORP (ACTG) - Dilution Analysis

Visualizing historical and potential share dilution over time

Dilution Analysis

Medium Risk
Moderate dilution risk
Last updated: May 07, 2026

Risk Assessment Details

Potential Dilution: 105.21% of current shares
Recent Dilution: 0.49% (2 years)
Historical Dilution Factor: minimal recent dilution
Outstanding Shares
96M
Potential Supply
100M
Additional shares possible
Splits
None
Past 2 years

Summary

ACTG currently has 96.5M outstanding shares. with significant dilution risk as 102M authorized shares could dilute existing holders by 105.2%. The company has minimally diluted shareholders by 0.49% over the past 2 years.

Share Structure Timeline

Outstanding Shares
Total Supply

Historical Data Points

Date Event Outstanding Supply
May 07, 2026

10-Q filing | 96.5M shares outstanding

96M 100M
Nov 06, 2025

10-Q filing | 96.4M shares outstanding

96M 100M
May 09, 2025

10-Q filing | 96.0M shares outstanding

96M 100M
Mar 17, 2025

10-K filing | 99.2M shares outstanding

99M 99M
Nov 12, 2024

10-Q filing | 99.9M shares outstanding

100M 98M
Aug 08, 2024

10-Q filing | 100.1M shares outstanding

100M 98M
May 10, 2024

10-Q filing | 99.7M shares outstanding

100M 98M
Mar 15, 2024

10-K filing | 92.4M shares outstanding

92M 110M
Mar 14, 2024

8-K filing: Acacia Research Corporation's Board approved a stock repurchase program on November 9, 2023, authorizing the company to purchase up to $20 million of its common stock, capped at 5,800,000 shares. ($20.0M proceeds)

100M 98M
Nov 13, 2023

10-Q filing | 99.1M shares outstanding

99M 99M
Nov 13, 2023

8-K filing: Acacia Research Corporation's Board of Directors approved a stock repurchase program authorizing the Company to purchase up to $20 million of its common stock, capped at 5,800,000 shares. ($20.0M proceeds)

100M 98M
Aug 03, 2023

10-Q filing | 99.9M shares outstanding

100M 98M
Aug 01, 2023

8-K filing: Acacia Research Corporation amended its bylaws on July 27, 2023, to permit a majority of independent directors to appoint a Lead Independent Director and updated procedures for stockholder proposals. Additionally, 350,000 shares of Series A Convertible Preferred Stock were converted into common stock and subsequently retired, reducing the total number of authorized shares of Series A Convertible Preferred Stock.

100M 98M
Jul 17, 2023

8-K filing: Starboard converted 350,000 shares of Series A Convertible Preferred Stock into 9,616,746 shares of Common Stock and exercised 31,506,849 Series B Warrants for 31,506,849 shares of Common Stock, cancelling $60 million of senior secured notes and receiving $55 million in gross proceeds. ($55.0M proceeds)

100M 98M
May 11, 2023

10-Q filing | 58.6M shares outstanding

59M 140M
Mar 17, 2023

10-K filing | 58.6M shares outstanding

59M 140M
Mar 06, 2023

8-K filing: The company completed a rights offering and concurrent private rights offering, resulting in the issuance of 68,753 shares and 15,000,000 shares of Common Stock, respectively, with Starboard Value LP participating in the private rights offering and becoming a significant shareholder. ($79.11M proceeds)

59M 140M
Nov 14, 2022

10-Q filing | 43.5M shares outstanding

44M 150M
Nov 01, 2022

8-K filing: Acacia Research Corporation entered into a Recapitalization Agreement with Starboard Value LP to restructure Starboard's investments in the Company, involving preferred stock conversion, warrant exercises, a rights offering, and a recapitalization payment.

38M 160M
Sep 30, 2022

8-K filing: Acacia Research Corporation amended the Series B Warrants to further extend the Cash Exercise Date from September 30, 2022 to October 28, 2022 to allow for additional time to reach a resolution with Starboard Value LP.

38M 160M
Sep 15, 2022

8-K filing: Acacia Research Corporation amended the Series B Warrants for a second time to extend the Cash Exercise Date from September 15, 2022, to September 30, 2022, to allow for additional time to reach a resolution with Starboard.

38M 160M
Aug 24, 2022

8-K filing: Acacia Research Corporation amended Series B Warrants to extend the Cash Exercise Date to September 15, 2022, allowing for potential resolution with Starboard Value LP and permitting cash payment for the lower exercise price of $3.65 for 31,506,849 warrants.

38M 160M
Aug 11, 2022

10-Q filing | 38.3M shares outstanding

38M 160M
May 12, 2022

10-Q filing | 46.5M shares outstanding

47M 150M
Mar 31, 2022

10-K filing | 48.8M shares outstanding

49M 150M
Nov 15, 2021

10-Q filing | 48.9M shares outstanding

49M 150M
Aug 16, 2021

10-Q filing | 48.7M shares outstanding

49M 150M
May 17, 2021

10-Q filing | 48.6M shares outstanding

49M 150M
Apr 06, 2021

8-K filing: Acacia Research Corporation, through its subsidiary Merton Acquisition HoldCo LLC, issued an additional $50 million in senior secured notes to Starboard Value LP on March 31, 2021, as part of a Second Supplemental Agreement, bringing the total outstanding amount of Merton Notes to $115 million.

49M 150M
Mar 29, 2021

10-K filing | 48.8M shares outstanding

49M 150M
Nov 19, 2020

S-3/A filing: Acacia Research Corporation files an S-3/A form for a shelf offering of common stock, preferred stock, and debt securities, with a total proposed amount of $100,000,000, and registers 148,965,762 shares of common stock offered by selling stockholders.

49M 150M
Nov 09, 2020

10-Q filing | 48.5M shares outstanding

48M 150M
Nov 09, 2020

S-3 filing: Acacia Research Corporation is filing an S-3 to offer common stock, preferred stock and debt securities with an aggregate initial offering price not to exceed $100,000,000. Also, selling stockholders may offer and sell up to an aggregate of 148,965,762 shares of common stock.

49M 150M
Aug 10, 2020

10-Q filing | 49.0M shares outstanding

49M 0
Jul 20, 2020

8-K filing: Acacia Research Corporation entered into a Securities Purchase Agreement with Starboard Value LP for the issuance of preferred shares and warrants.

49M 0
Jun 10, 2020

8-K filing: Acacia Research Corporation entered into a Transaction Agreement with LF Equity Income Fund to acquire a portfolio of securities of 19 public and private life sciences companies for £223.9 million, and issued $115 million principal amount of Senior Secured Notes to Starboard in connection with the Portfolio Transaction.

49M 0
May 11, 2020

10-Q filing | 48.7M shares outstanding

49M 0
Mar 16, 2020

10-K filing | 50.9M shares outstanding

51M 0
Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam Unsubscribe anytime